
About the HIV/AIDS Session
HIV/AIDS, caused by the human immunodeficiency virus (HIV), remains a critical public health challenge. This viral infection attacks the immune system, gradually weakening its ability to fight off infections and diseases. HIV is primarily transmitted through unprotected sexual intercourse, sharing of contaminated needles, and from an infected mother to her child during childbirth or breastfeeding, as well as through blood transfusions and organ transplantations with infected blood or tissues. The progression of HIV involves distinct stages, with the initial infection often presenting flu-like symptoms. However, individuals can remain asymptomatic for an extended period. Without proper medical intervention, HIV can advance to acquired immunodeficiency syndrome (AIDS), characterized by a severe depletion of immune cells, leaving the individual susceptible to opportunistic infections and certain cancers. Preventive measures play a crucial role in controlling the spread of HIV. These include promoting safe sex practices, ensuring the use of sterile needles, and implementing strategies to prevent mother-to-child transmission. Antiretroviral therapy (ART) is a cornerstone of HIV management, helping control viral replication and allowing individuals with HIV to lead healthier lives. Additionally, ART significantly reduces the risk of transmitting the virus to others. While there is no cure for HIV/AIDS, advancements in medical treatments have transformed the prognosis for those living with the virus. Early detection, access to healthcare, and adherence to treatment regimens have become pivotal in managing the disease and preventing its progression to AIDS. Global efforts in HIV/AIDS awareness, prevention, and treatment continue to make significant strides. Destigmatizing the condition remains a priority to encourage testing, promote open dialogue, and ensure a supportive environment for those affected by HIV/AIDS. The goal is to create a world where individuals living with HIV can access proper care, lead fulfilling lives, and contribute to the broader efforts to curb the spread of the virus.
Topics Covered in HIV/AIDS
HIV testing and early diagnosis
Antiretroviral therapy and treatment adherence
Prevention of mother-to-child transmission
Pre-exposure prophylaxis and combination prevention
Opportunistic infections and coinfection management
HIV stigma, disclosure and support services
Featured Speakers — HIV/AIDS 2027


Recent Research Presented at HIV/AIDS Sessions
Predictive approaches for cardiovascular disease and stroke risk among people living with HIV: A narrative review
Background: Cardiovascular Disease (CVD) and stroke have emerged as the leading causes of non-AIDS-related mortality among People Living with HIV (PLWH) in the Antiretroviral Therapy (ART) era.…
Incidence rate and predictors of aids occurrence among adults living with HIV at a national tertiary referral hospital in Oman, 1992–2024: An ambidirectional cohort study
Background: Despite advances in human immunodeficiency virus (HIV) care globally, HIV remains a major public health challenge, particularly in the Middle East and North Africa (MENA) region. Although…
Behavioral and socio-demographic determinants of HIV, syphilis and HCV infections among VCT clients in Poland in 2015-2025, including the war refugee population from Ukraine
Background: Large migration flows from Ukraine (a country with one of the highest HIV/STI infection rates in Europe) to European countries, mainly to Poland, elevates the risk of an increase in the…
Socioeconomic inequalities in HIV/AIDS mortality in Colombia (2008-2024): A nationwide study
Background: Colombia has the fourth highest incidence rate of HIV/AIDS among countries in the Americas, with a progressive increase since 1990. In addition, HIV/AIDS (excluding tuberculosis) remains…
From descriptive epidemiology to intervention science: Lessons learned from the cardiovascular status of adults living with HIV in Panama
Background: Adults living with HIV (ALWH) are at an increased risk of cardiometabolic disease due to chronic inflammation, immune activation, and side effects of antiretroviral therapy (ART). The…
Addressing COVID-19 disparities through an HIV framework
The prolific spread of COVID-19 in the U.S. has overburdened our clinical healthcare system and magnified significant gaps in the delivery of care. In a matter of months, stark disparities in…
Related Scientific Sessions at IPHC 2027
Why Attend the HIV/AIDS Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original HIV/AIDS work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping HIV/AIDS research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the HIV/AIDS track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
HIV/AIDS Conference 2027 — FAQs
What is the HIV/AIDS track at IPHC 2027?
The HIV/AIDS track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in HIV/AIDS. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the HIV/AIDS sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in HIV/AIDS are all welcome — whether presenting or attending.
Can I present my research in the HIV/AIDS track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for HIV/AIDS sessions?
Yes. IPHC 2027 is a hybrid conference — attend the HIV/AIDS track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
